Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Dyspnea × Sugars × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 7 cyclopia sequence 6 Lung Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Urinary Bladder Neoplasms 2 Prostatic Neoplasms 2 Polycystic Ovary Syndrome 2 Neoplasms, Plasma Cell 2 Neoplasm Metastasis 2 Multiple Myeloma 2 Hematologic Diseases 2 Head and Neck Neoplasms 2 Warts 1 Squamous Cell Carcinoma of Head and Neck 1 Small Cell Lung Carcinoma 1 Recurrence 1 Prostatic Intraepithelial Neoplasia 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Precancerous Conditions 1 Papilloma 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Oropharyngeal Neoplasms 1 Non-Muscle Invasive Bladder Neoplasms 1 Neoplasms 1 Melanoma 1 Male Urogenital Diseases 1 Lymphoma 1 Lymphangioleiomyomatosis 1 Lower Urinary Tract Symptoms 1

Interventions

Surveys and Questionnaires 4 Dexamethasone 2 Calcium Dobesilate 2 dexamethasone acetate 1 dexamethasone 21-phosphate 1 auricularum 1 Tiotropium Bromide 1 Sugars 1 Midazolam 1 Lisinopril 1 Dexmedetomidine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01670097 2021-02-17

Dexamethasone Dyspnea Study

M.D. Anderson Cancer Center

Phase 2 Completed

52 enrolled 13 charts

Dyspnea, Hematologic Diseases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡